Comera Life Sciences Holdings, Inc.
12 Gill Street, Suite 4650
Woburn, Massachusetts 01801
September 11, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Comera Life Sciences Holdings, Inc.
Registration Statement on Form S-3
File No. 333-274253
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Comera Life Sciences Holdings, Inc. hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-274253) so that it may become effective at 4:00 p.m. Eastern time on September 13, 2023, or as soon thereafter as practicable.
[Remainder of this page intentionally left blank]
|
|
|
Very truly yours, | ||
| ||
Comera Life Sciences Holdings, Inc. | ||
|
| |
By: | /s/ Jeffrey S. Hackman | |
Name: | Jeffrey S. Hackman | |
Title: | Chairman, President and CEO | |
